Dr Ash Malalasekera | Chris O'Brien Lifehouse
Dr Ash MalalasekeraMedical Oncologist

    Dr Ash Malalasekera

    Medical Oncology and Cancer Survivorship

    FRACP, PhD

    CONTACT:

    Phone: (02) 8514 0636
    Email: alison.sibley@lh.org.au

    Ash Malalasekera  is a medical oncologist and clinician researcher with more than six years experience working for cancer survivors.

    Her vision is to work with patients and carers to show that evidence-based multidisciplinary care delivered in tandem with supportive care from the time of diagnosis improves outcomes and experience for people living with and surviving cancer.

    Ash received the Young Investigator Grant from the International Association for the Study of Lung Cancer in 2019 for research into cancer-related fatigue and the Cancer Institute NSW Innovations in Cancer Control grant in 2020 for research on equity of cancer care for multicultural communities.

    • Senior Clinical Lecturer, University of Sydney
    • Survivorship Research Group, COSA, PC4, IASLC, MOGA, PACCSC.
    • Steering committees: 2021 LFA LUCAS Working Group, 2018 Cancer Australia Optimal Care Pathways Project Steering Committee, 2019 ‘RE-ENGAGE’ Pilot study in Childhood Cancer Survivors, 2019 Cancer Australia exemplar care and referral pathway for breast cancer care.

    TIMES TO DIAGNOSIS AND TREATMENT OF LUNG CANCER IN NSW, AUSTRALIA: A MULTI-CENTRE, MEDICARE DATA-LINKAGE STUDY
    A Malalasekera, P Blinman, H Dhillon, N Stefanic, P Grimison, A Jain, M D’Souza, S Kao, J Vardy. Journal of Oncology Practice 2018 14:10

    DELAYS TO DIAGNOSIS AND TREATMENT OF PEOPLE WITH LUNG CANCER IN AUSTRALIA: HEALTH CARE PROFESSIONAL PERCEPTIONS OF ACTUAL VERSUS ACCEPTABLE TIMEFRAMES
    A Malalasekera, H Dhillon, P Blinman, S Kao, J Vardy. Internal Medicine Journal 2018 SEP; 48(9):1063-1071

    HOW LONG IS TOO LONG? A SCOPING REVIEW OF HEALTH SYSTEM DELAYS IN LUNG CANCER
    A Malalasekera, S Nahm, P Blinman, S Kao, H Dhillon, J Vardy. European Respiratory Review 2018 27: 180045.

    WHY DO DELAYS TO DIAGNOSIS AND TREATMENT OF LUNG CANCER OCCUR? A MIXED METHODS STUDY OF INSIGHTS FROM AUSTRALIAN CLINICIANS
    A Malalasekera, C Shunmugum, H Dhillon, P Blinman, S Kao, J Vardy. Asia-Pacific Journal of Clinical Oncology 2020; 1-10.

    HEALTH STATUS AND WELL BEING OF CANCER SURVIVORS ATTENDING THEIR FIRST APPOINTMENT AT THE SYDNEY SURVIVORSHIP CLINIC
    C Tan, J Turner, K Kerin-Ayres, S Butler,..A Warby, I Cunningham, A Malalasekera, HM Dhillon, JL Vardy

    WHAT HAPPENS TO CANCER SURVIVORS ATTENDING A STRUCTURED CANCER SURVIVORSHIP CLINIC? SYMPTOMS, QUALITY OF LIFE AND LIFESTYLE CHANGES OVER THE FIRST YEAR AT THE SYDNEY CANCER SURVIVORSHIP CENTRE CLINIC
    JL Vardy,……A.Malalasekera, C Tan. Supportive Care in Cancer 2020.

    Contact Us

    We're not around right now. But you can send us an email and we'll get back to you, asap.

    Not readable? Change text. captcha txt

    Start typing and press Enter to search